Product Information

TEMOZOLOMIDE 5 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $7.0598 per EA under NDC 47335089021. Its NADAC has been published 89 times since Apr 9, 2014.

FDA first approved this application on Feb 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for TEMOZOLOMIDE 5 MG CAPSULE has been published 89 times since Apr 9, 2014, and over the history we have for it it has declined 17.0%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 73% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.